Oncology Medical News about mammographic screening

Your Unread Messages

See All

Tracy Hampton, PhD

FDA Update

New Vaccine Approved for Cervical Cancer

Roberta Buell, MBA
Congress Proposes SGR Fix

Dorothy J. Schirf, MD

Technology Advances

Radiosurgery Trial Sparks Optimism for Early Lung Cancer

Sara Hartley

Cancer Science

Using Embryonic Stem Cells to Test Breast Cancer Genes

See All Messages (38 new messages)

Hello, Suzanne Dixon
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence
European Journal of Cancer, 11/05/09

Donella P et al. – Overdiagnosis of breast cancer in Florentine service screening can be estimated only for women aged 60–69 years at the start of service screening, for it is only for this group that a sufficient follow–up period is available after the last screening. The data show that 15 years after the introduction of mammographic service screening the degree of overdiagnosis was nearly zero and more than likely lower than 13% in this age group.

<< Previous
Dose-intensified epirubicin versus standard-dose...

Next >>
Radiation therapy and tamoxifen after breast-conserving surgery:...